心不全の予防のための最適な血清セレニウム範囲の探索:米国の成人におけるU型関連と肝硬変によるメディエーション
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
PubMedで要約を見る
まとめ
この要約は機械生成です。血清セレニウム濃度は,低濃度と高濃度の両方がリスクを増加させるため,心不全のリスクとU型関連を示しています. 肝硬変と脂質不全は,この関係を媒介し,複雑な相互作用を示唆する可能性があります.
科学分野
- 心血管疾患の疫学
- 栄養学的生化学
- 代謝 健康
背景
- 血清セレニウム濃度と心不全 (HF) の発生率との関連はよく定義されていません.
- 肝硬変や脂質不全などの潜在的な媒介因子の理解は,この関連性を明らかにするために極めて重要です.
研究 の 目的
- 血清セレニウム濃度と心不全のリスクとの非線形関係を調査する.
- セレニウムと心不全の関連性における肝硬化症と不血脂症の作用を調査する.
- メンデルのランダム化を使って 潜在的因果関係を推論する
主な方法
- 国民健康栄養調査 (NHANES) 2017-2020における6969人の成人のデータを分析した.
- セレニウムHFのリスクを評価するために,ロジスティック回帰,制限された立方スプレーン,ランダムな森林モデルを適用する.
- 媒介分析とメンデルのランダム化により,間接的な効果と因果関係を評価する.
主要な成果
- 血清セレニウムと心不全のリスクとの非線形関連が示された (非線形性のP=0. 003).
- 血清セレニウム濃度が最適以下と高すぎるとともに,心不全の危険性が高かった.
- セレニウムと心不全との関連が部分的に媒介された.
結論
- 血清セレニウム曝露と心不全のリスクとの間には非線形的な関係がある.
- 肝臓ステアトーシスと脱脂症は,この関連に関与する主要な代謝経路を表す可能性があります.
- 臨床応用の可能性を明らかにするために,さらなる研究が必要である.
関連する概念動画
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...